Table 4. Comparison of outcomes between published series of appendix cancer.
| Series (n) | Stage 1 % (n) | Stage 2 % (n) | Stage 3 % (n) | |
|---|---|---|---|---|
| 5-Year recurrence | MSKCC (70) | 0 % (6) | 4 (50) | 78 (14) |
| MGH2 (15) | 60 (15)a | |||
| 5-Year disease-specific survival | MSKCC (70) | 100 (6) | 97 (50) | 83 (14) |
| Mayo1 (67) | 100 (9) | 67 (37) | 50 (21) | |
| German3 (NA) | 100 (NA) | 79–88 (NA) | 25–39 (NA) | |
MSKCC, Memorial Sloan Kettering Cancer Center; MGH, Massachusetts General Hospital; NA, number of patients not available by stage
a
Recurrence not reported by stage